← Back to headlines
Analysts Bullish on Dyne Following Rare Disease Drug Progress in Japan
Analysts are bullish on Dyne after the company made progress with its rare disease drug in Japan.
19 Feb, 00:38 — 19 Feb, 00:38
Analysts are bullish on Dyne after the company made progress with its rare disease drug in Japan.
19 Feb, 00:38 — 19 Feb, 00:38
